GEIST:UPC Searchengine

ORD_66752/2024

Curio Bioscience, Inc v. 10x Genomics, Inc.

Datum
2024-12-17
Kammer
Luxembourg (LU)
Verfahrensart
Application Rop 223
Sprache
EN

Metadaten

Fall-IDORD_66752-2024-3e4f69c61be3
Aktenzeichen
RegisterzeichenORD_66752/2024
EntscheidungsreferenzORD_66752/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 3

1 Reference no.: UPC_CoA_810/2024 App_66516/2024 Order of the Court of Appeal of the Unified Patent Court issued on 17 December 2024 concerning an application for suspensive effect (Rule 223.4 RoP) HEADNOTES: The requirement of an extreme urgency under R 223 RoP has to be established by the applicant. In the present case, the applicant has not evidenced the existence of an extreme urgency. KEYWORDS: Suspensive effect of the appeal, R 223 ROP. APPELLANT AND DEFENDANT IN THE MAIN PROCEEDINGS BEFORE THE COURT OF FIRST INSTANCE Curio Bioscience Inc., 4030 Fabian Way, Palo Alto, CA 94303, USA (hereafter referred to as “Curio” or “applicant”) represented by Cameron Marshall and Agathe Michel-de Cazotte, UPC representatives, Carpmaels & Ransford LLP RESPONDENT AND CLAIMANT IN THE MAIN PROCEEDINGS ...